Contribution: Industrial Research Assistance Program – Contributions to Firms
Aspect Biosystems Ltd.
$841,683.00
Improvements to bioprinted pancreatic and liver tissues for clinical applications
FY 2022-23 · 2022-09-01
Summary
This project will support the firm to achieve key development and regulatory milestones for their bioprinted pancreatic tissue therapeutic for Type 1 Diabetes to advance to final IND-enabling studies, and to demonstrate their 3D bioprinting technology is a biomanufacturing platform by showing efficacy of bioprinted liver tissues in multiple liver diseases.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
830167839
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2022-09-01 | 2022-23 | $600,183.00 |
| 1 | 2022-09-01 | 2022-23 | $675,183.00 |
| 2 | 2022-09-01 | 2022-23 | $841,683.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 166,500 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 166 500 dollars.
Agreement End Date
2023-10-31
Agreement Number
997886
Agreement Start Date
2022-09-01
Agreement Title
Improvements to bioprinted pancreatic and liver tissues for clinical applications
Agreement Title (French)
Améliorations des tissus pancréatiques et hépatiques bio-imprimés pour les applications cliniques
Agreement Type
Contribution
Agreement Value
$841,683.00
Amendment Date
2023-09-25
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will support the firm to achieve key development and regulatory milestones for their bioprinted pancreatic tissue therapeutic for Type 1 Diabetes to advance to final IND-enabling studies, and to demonstrate their 3D bioprinting technology is a biomanufacturing platform by showing efficacy of bioprinted liver tissues in multiple liver diseases.
Description (French)
Ce projet permettra à l’entreprise de franchir des étapes clés en matière de développement et de réglementation pour le traitement du diabète de type 1 par bio-impression de tissus pancréatiques, afin de passer aux études finales de validation de la demande d’autorisation de drogue nouvelle (IND), et de démontrer que sa technologie de bio-impression en 3D est une plateforme de bioproduction en montrant l’efficacité des tissus hépatiques bio-imprimés dans plusieurs maladies du foie.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
830167839
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Aspect Biosystems Ltd.
Recipient Operating Name
Aspect Biosystems
Recipient Postal Code
V6P 6P2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2022-2023-Q3-997886
